SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?

ABSTRACT:

Purpose

Seroprevalence surveys from different countries have reported SARS CoV-2 antibodies below 20% even in the most adversely affected areas and herd immunity cannot be predicted till more than half of the population gets the disease. The purpose of this survey was to estimate the magnitude of community-based spread of the infection, associated immunity, and the future prospects and proximity to a 'herd community'.

Methods

The study was undertaken as a cluster randomized, cross-sectional countrywide survey. This largest community-based seroprevalence data of SARS-CoV-2 were collected between 15th and 31st July, 2020 from seven randomly selected cities belonging to the three most populous provinces of Pakistan. The FDA approved kit of ROCHE was used for detection of SARS-C

SUBMITTER: Haq M 

PROVIDER: S-EPMC8145183 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature